Faculty profile

Osnat Melamed

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Osnat Melamed

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
12 publications in the last five years, latest in 2026.
Principal investigator on 3 research grants (3 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Gender Addiction Cardiometabolic Risk Gastric Inhibitory Peptide Glucagon-Like Peptide-1 Receptor Agonist Nicotine Dependence Obesity Overweight

Latest papers

The health effects of vaping and e-cigarettes: consensus recommendations
International Journal of Drug Policy · 2026
Using the behaviour change wheel framework to develop a rule-based chatbot to support varenicline adherence for smoking cessation.
Digital health · 2025
Cognitive Dysfunction in the Addictions (CDiA): protocol for a neuron-to-neighbourhood collaborative research program.
Frontiers in psychiatry · 2025

All 13 publications

Latest funding

The SWAGAT Study: Smoking cessation and Weight gain Attenuation with dual Glucagon like Peptide Receptor & Gastric Inhibitory Receptor Agonist- Tirzepatide: A double blinded RCT.
CIHR · 2026 · Principal investigator
$100,000
Assessing ChatV's Feasibility in Promoting Varenicline Adherence: A Hybrid Type 1 Study
CIHR · 2025 · Co-investigator
$569,925
Enhancing Motivation for Smoking Cessation in Women Using a Gender-Informed AI Conversational Agent: Development and Feasibility Study
CIHR · 2025 · Nominated PI
$558,193

All 10 grants and awards

13 publications.

The health effects of vaping and e-cigarettes: consensus recommendations

Kouzoukas E, Navas C, Zawertailo L, Fougere C, Bacon SL, Chadi N, Evans WK, McNeill A, Melamed O, Moraes TJ

International Journal of Drug Policy20265 citations

DOI: 10.1016/j.drugpo.2025.105117

Using the behaviour change wheel framework to develop a rule-based chatbot to support varenicline adherence for smoking cessation.

Minian N, Mehra K, Rose J, Veldhuizen S, Zawertailo L, Ratto M, Ting-A-Kee R, Melamed O, Tang V, Selby P

Digital health2025

DOI: 10.1177/20552076251380324 PMID: 40995424

Cognitive Dysfunction in the Addictions (CDiA): protocol for a neuron-to-neighbourhood collaborative research program.

Nikolova YS, Ruocco AC, Felsky D, Lange S, Prevot TD, Vieira E, Voineskos D, Wardell JD, Blumberger DM, Clifford K, Naik Dharavath R, Gerretsen P, Hassan AN, Hope IM, Irwin SH, Jennings SK, Le Foll B, Melamed O, Orson J, Pangarov P, Quigley L, Russell C, Shield K, Sloan ME, Smoke A, Tang V, Valdes Cabrera D, Wang W, Wells S, Wickramatunga R, Sibille E, Quilty LC

Frontiers in psychiatry2025

DOI: 10.3389/fpsyt.2025.1455968 PMID: 40462873

Cognitive Dysfunction in the Addictions (CDiA): A Neuron to Neighbourhood Collaborative Research Program on Executive Dysfunction and Functional Outcomes in Outpatients Seeking Treatment for Addiction.

Nikolova YS, Ruocco AC, Felsky D, Lange S, Prevot TD, Vieira E, Voineskos D, Wardell JD, Blumberger DM, Clifford K, Dharavath RN, Gerretsen P, Hassan AN, Jennings SK, Le Foll B, Melamed O, Orson J, Pangarov P, Quigley L, Russell C, Shield K, Sloan ME, Smoke A, Tang V, Cabrera DV, Wang W, Wells S, Wickramatunga R, Sibille E, Quilty LC, CDiA Program Study Group

medRxiv : the preprint server for health sciences2024

DOI: 10.1101/2024.08.30.24312806 PMID: 39252904

Developing standards for virtual delivery of mental health services in Canadian primary care: A qualitative study and modified Delphi process.

Yusuf A, Salvalaggio G, Melamed O, Montesanti S, Atherton H, Langford L, Sediqzadah S, Amaral TD, O'Neill B

PLOS mental health2024

DOI: 10.1371/journal.pmen.0000071 PMID: 41661740

A Motivational Interviewing Chatbot With Generative Reflections for Increasing Readiness to Quit Smoking: Iterative Development Study.

Brown A, Kumar AT, Melamed O, Ahmed I, Wang YH, Deza A, Morcos M, Zhu L, Maslej M, Minian N, Sujaya V, Wolff J, Doggett O, Iantorno M, Ratto M, Selby P, Rose J

JMIR mental health2023

DOI: 10.2196/49132 PMID: 37847539

Augmenting varenicline treatment with transcranial direct current stimulation (tDCS) increases smoking abstinence rates at end of treatment.

Zhang H, Rajji TK, Selby P, Melamed O, Attwells S, Zawertailo L

Brain stimulation2023

DOI: 10.1016/j.brs.2023.07.001 PMID: 37406928

Disruptions in Primary Care among People with Schizophrenia in Ontario, Canada, During the COVID-19 Pandemic.

Stephenson E, Yusuf A, Gronsbell J, Tu K, Melamed O, Mitiku T, Selby P, O'Neill B

Canadian journal of psychiatry. Revue canadienne de psychiatrie2023

DOI: 10.1177/07067437221140384 PMID: 36453004

Outcomes Among People With Schizophrenia Participating in General-Population Smoking Cessation Treatment: An Observational Study.

Veldhuizen S, Behal A, Zawertailo L, Melamed O, Agarwal M, Selby P

Canadian journal of psychiatry. Revue canadienne de psychiatrie2023

DOI: 10.1177/07067437231155693 PMID: 36760089

The Role of Personality Risk and Protective Factors in Living with Covid-19: A Longitudinal Study.

Shulman S, Stein J, Melamed O, Muchaeli Y, Hakhmigari-Kalfon M

Journal of adult development2023

DOI: 10.1007/s10804-023-09439-6 PMID: 36789170

Something wrong or missing on this profile? Suggest a correction

Osnat Melamed

Research

Latest papers

Latest funding

The health effects of vaping and e-cigarettes: consensus recommendations

Using the behaviour change wheel framework to develop a rule-based chatbot to support varenicline adherence for smoking cessation.

Cognitive Dysfunction in the Addictions (CDiA): protocol for a neuron-to-neighbourhood collaborative research program.

Cognitive Dysfunction in the Addictions (CDiA): A Neuron to Neighbourhood Collaborative Research Program on Executive Dysfunction and Functional Outcomes in Outpatients Seeking Treatment for Addiction.

Developing standards for virtual delivery of mental health services in Canadian primary care: A qualitative study and modified Delphi process.

A Motivational Interviewing Chatbot With Generative Reflections for Increasing Readiness to Quit Smoking: Iterative Development Study.

Augmenting varenicline treatment with transcranial direct current stimulation (tDCS) increases smoking abstinence rates at end of treatment.

Disruptions in Primary Care among People with Schizophrenia in Ontario, Canada, During the COVID-19 Pandemic.

Outcomes Among People With Schizophrenia Participating in General-Population Smoking Cessation Treatment: An Observational Study.

The Role of Personality Risk and Protective Factors in Living with Covid-19: A Longitudinal Study.

A Natural Language Chatbot for Smoking Addiction

Frequent collaborators

Peter Selby

Scott Veldhuizen

Nadia Minian

Victor Tang

Erica Vieira

Samantha Wells

Shannon Lange

Braden O’Neill

Wei Wang

Etienne Sibille

Daniel Felsky

Philip Gerretsen

Bernard Le Foll

Kevin Shield

Samantha Wells

Daphne Voineskos

Margaret Hahn

Marta Maslej

Mahavir Agarwal

Rahim Moineddin

Ginetta Salvalaggio

William Evans

Aristotle Voineskos

Karen Tu

Robert Schwartz

Stephanie Montesanti